ABSTRACT: Genetic factors have been shown to be a small but significant predictor for osteoporosis and osteoporotic fracture risk. We performed a case-control association study to determine the association between miR-146a, miR-149, miR-196a2, and miR-499 polymorphisms and osteoporotic vertebral compression fracture (OVCF) susceptibility. In total, 286 unrelated postmenopausal Korean women (57 with OVCFs, 55 with non-OVCFs, and 174 healthy controls) were recruited. All subjects underwent dual energy X-ray absorptiometry to determine BMD at the lumbar spine and femoral neck. We focused on four single nucleotide polymorphisms (SNPs) of pre-miRNA sequences including miR-146aC>G (rs2910164), miR-149T>C (rs2292832), miR-196a2T>C (rs11614913), and miR-499A>G (rs3746444). Genotype frequencies of these four SNPs were determined using polymerase chain reaction-restriction fragment length polymorphism analysis. The TT genotype of miR-149aT>C was less frequent in subjects with OVCFs, suggesting a protective effect against OVCF risk (Odds ratio [OR], 0.435; 95% confidence interval [CI], 0.22-0.85, p ¼ 0.014), whereas the miR-146aCG/ miR-196a2TC combined genotype was more frequent in OVCF patients (OR, 5.163; 95%CI,, p ¼ 0.043), suggesting an increase in OVCF risk. Additionally, combinations of miR-146a, -149, -196a2, and -449 showed a significant association with increased prevalence of OVCFs in postmenopausal women. In particular, the miR-146aG/-149T/-196a2C/-449G allele combination was significantly associated with an increased risk of OVCF (OR, 35.01; 95% CI, 1.919-638.6, p ¼ 0.001). Our findings suggest that the TT genotype of miR-149aT>C may contribute to decreased susceptibility to OVCF in Korean postmenopausal women. Conversely, the miR-146aCG/ miR-196a2TC combined genotype and the miR-146aG/-149T/-196a2C/-449G allele combination may contribute to increased susceptibility to OVCF.
Osteoporosis is a common metabolic bone disease of postmenopausal women characterized by low bone mass and microarchitectural deterioration of bone tissue that causes decreased bone strength and increase risk of fracture. 1 Osteoporotic vertebral compression fractures (OVCFs) are the most common osteoporotic fracture in postmenopausal women, accounting for $27% of all osteoporotic fractures in both men and women. 2 OVCFs commonly occur in postmenopausal women, leading to high risk of morbidity and mortality. Furthermore, the incidence of new fractures increases after an initial fracture, resulting in increased mortality. 3 Bone mineral density (BMD) has been used for the diagnosis of osteoporosis and it has been considered as one of the best predictors of OVCF. 4 However, BMD measurement alone is insufficient to find the high-risk individuals because even osteopenic patients can develop vertebral compression fractures. 5 Other potential predictors of OVCF are biochemical markers of bone turnover, skeletal geometry, and genetic factors. It has been reported that genetic factors may contribute to variation in BMD [6] [7] [8] as well as osteoporotic fracture risk. 4, 9, 10 Postmenopausal osteoporosis results from disequilibrium of osteoclastic bone resorption and osteoblastic bone formation. microRNAs (miRNAs) have been known to participate in the control of bone resorption and bone formation. 11 miRNAs are small non-coding RNA molecules and repress translation of target messenger RNAs (mRNAs) by binding to the 3 0 -untranslated regions (3 0 -UTR) of mRNAs. Single nucleotide polymorphisms (SNPs) in the 3 0 -UTR of mRNAs have been reported to potentially change the binding affinity between a miRNA and its targets and could contribute to diminished bone density. 12 In this study, we hypothesized that sequence variations in pre-miRNAs could influence the development of OVCFs. Among reported SNPs in pre-miRNA genes, we investigated whether four well-known miRNA polymorphisms (miR-146aC>G [rs2910164], miR-149T>C [rs2292832], miR-196a2T>C [rs11614913], and miR-499A>G [rs3746444]) could contribute an increased risk of OVCFs in Korean postmenopausal women. The rs2292832 SNP is present outside the mature region of pre-mir-149; the three other SNPs (rs2910164, rs11614913, and rs3746444) are located in the 3p strand of mature miRNA regions, and they may affect both the binding of 3p mature miRNA to its target mRNAs and the pre-miRNA maturation of 5p and 3p strands miRNAs. The miRNAs mature form expression and biogenesis levels can be altered by SNPs of pre-miRNAs, and it contributes to the occurrence and development of the diseases. Recently, four functional SNPs in pre-miRNAs (miR-146aC>G [rs2910164], miR-149T>C
[rs2292832], miR196a2T>C
[rs11614913], and miR-499A>G [rs3746444]) have been deposited in the public miRNA database. SNPs in human miRNA genes have been reported to be associated with human susceptibility to various diseases. [13] [14] [15] Furthermore, miRNA expression has also been shown to be related to osteogenesis 16 and affects the formation of bone mass. 17 Therefore, we hypothesized that miRNA SNPs of miR-146a, miR196a2, and miR-499 could contribute an increased risk of OVCFs. The four SNPs located at the pre-miRNA region can have an effect on mature miRNA expression as well as target mRNA expression. [18] [19] [20] [21] [22] [23] [24] [25] These four miR polymorphisms were selected for investigation based on published evidence for their involvement in bone metabolism. miR-146a (accession number: MIMAT0000449) has been reported to play a crucial role in the regulation of osteoclastogenesis 22 and osteogenic differentiation of mesenchymal stem cells (MSCs). 17, 26 miR-196a2 (accession number: MIMAT0000226) promotes commitment of MSCs toward the osteoblast lineage possibly through its target gene Hoxc8, and miR-196a2 SNPs could influence skeletal phenotype because Hox genes play an important role in endochondral bone formation and cartilage production. 27 
miR-149
(accession number: MIMAT0000450) and miR-499 (accession number: MIMAT0002870) have been reported to directly target inflammatory cytokines including IL-1b, IL-6, and TNF-a, and polymorphisms in miR-149 and miR-499 could be associated with osteoarthritis and rheumatoid arthritis, respectively [27] [28] [29] (Fig. 1) . Recent studies revealed a potential association between inflammatory cytokines and osteoporotic fractures. 30, 31 Therefore, the four precursor miRNA SNPs in miR-146a, miR-149, miR-196a2, and miR-499 could contribute to an increased risk of OVCF. In the present study, we evaluated an association between these four SNPs and OVCF risk in Korean postmenopausal women.
METHODS

Study Design
We performed a case-control study to assess the influence of four SNPs in miR-146a (rs2910164), miR-149 (rs2292832), miR-196a2 (rs11614913), and miR-499 (rs3746444) on OVCF risk. The research was conducted in accordance with the principles described in the Declaration of Helsinki. The Institutional Review Board of CHA Bundang Medical Center (IRB number: BD2014-007) approved this study, and all participants provided written informed consent.
Study Population
The study group comprised 286 postmenopausal Korean women from the South Korean province of Gyeonggi-do. Postmenopausal women were recruited from the departments of neurosurgery and orthopedic surgery at CHA Bundang Medical Center. Korean postmenopausal women older than 50 years were eligible for inclusion in the study. The diagnosis of osteoporosis was based on the dual X-ray absorptiometry (DXA) (World Health Organization [WHO] criteria; hip or lumbar T-score À2.5 standard deviations), and an OVCF was diagnosed when a progressive or newly generated compression fracture was identified after lowenergy trauma. The study population consisted of 112 Korean postmenopausal women with osteoporosis and 174 healthy women without osteoporosis (control group). The subjects with osteoporosis consisted of 57 postmenopausal women with OVCFs (OVCF group) and 55 postmenopausal women without fractures (non-OVCF group).
All patients with osteoporosis fulfilled the following criteria: (1) absence of metabolic diseases such as; diffuse idiopathic skeletal hyperostosis, pituitary gland disorders, hyperthyroidism, rheumatoid arthritis, or hyperparathyroid- (A) Potential impact of miR-196a on osteoblasts, (B) potential impact of miR-146a on osteoclasts, and (C) potential impact of miR-146a and miR-149 on chondrocytes. Hoxc8, homeobox C8; OPN, osteopontin; TRAF-6, TNF receptor associated factor 6; NF-kB, nuclear factor kappa-light chain enhancer of activated B cell; FGF2, fibroblast growth factor 2.
MICRORNA POLYMORPHISMS IN OVCF 245 ism; (2) not taking drugs affecting bone metabolism or blood clotting including oral anticoagulants, oral contraceptives, hormone replacement therapy, corticosteroids, calcium, or vitamin D; (3) absence of seronegative spondyloarthropathy; (4) no history of stroke or ischemic heart disease; (5) no prior cancer diagnosis; and (6) of Korean descent. All patients were examined using conventional X-radiography, DXA, and MRI to evaluate the fracture configuration and acuity of the fracture. Whole body bone scanning was used in cases where MRI was contraindicated.
Control subjects were recruited from individuals who visited our hospital for health examinations. The control subjects had BMD T scores (lumbar spine and hip) higher than À1.0 and had no spine or hip fractures on conventional radiography. The exclusion criteria were the identical to those used in the patient group. Demographic features and comorbidities such as diabetes mellitus (DM) and hypertension, and cardio-cerebrovascular diseases were investigated in all subjects. Hypertension was defined as a systolic blood pressure (SBP) of 140 mmHg or more, or diastolic blood pressure (DBP) of 90 mmHg or more, including patients taking antihypertensive agents. DM was defined as fasting plasma glucose level 126 mg/dl or more, including patients receiving anti-diabetic drug. Blood was sampled from the all patients for measurement of folate, glucose, homocysteine, triglycerides (TG), low-density lipoprotein (LDL), high-density lipoprotein (HDL), and vitamin B12.
Genetic Analyses
Genotyping of the miR-146aC>G, miR-149T>C, miR196a2T>C, and miR-499A>G SNPs was performed in extracted leukocytes using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). One microliter from each sample was used to amplify the miR-146a, miR-149, miR-196a2, and miR-499 genes. The primers for RT-PCR were as designed using PrimerQuest software (Integrated DNA Technologies, Coralville, IA). The PCR of the miR-146aC>G SNP was performed using the following 0 . The SNPs in miR-146a, miR-149, miR-196a2, and miR-499 were determined by digestion of the PCR products with restriction endonucleases SacI, AluI, MspI, and BclI, respectively (New England BioLabs, Beverly, MA). The 12 ml reaction products were run on a 3.0% agarose gel containing ethidium bromide and visualized under ultraviolet. For each of the four SNPs, the second round of the PCR assays was performed after randomly choosing 10% of the PCR assays, followed by DNA sequencing to validate the results of PCR-RFLP analysis using an automatic sequencer (ABI3730x I DNA analyzer; Applied Biosystems, Forster City, CA). Concordance for quality control samples was 100%.
We conducted gene-gene interaction analysis among the four SNPS in miR-146a, miR-149, miR-196a2, and miR-499 genes using the multifactor dimensionality reduction (MDR) method (MDR software package, v.2.0, www.epistasis.org). We constructed all possible allele combinations of the four SNPs by MDR method. The frequencies of allele combinations for the polymorphisms were estimate using HAPSTAT software (v.3.0, www.bios.unc.edu/~lin/hapstat/).
Statistical Analyses
The genotype and allele combination frequencies were compared between cases (patients with osteoporosis, non-OVCF, and OVCF group) and controls using multivariate logistic regression and Fisher's exact test, respectively. Allele fre- AOR, adjusted odds ratio; OVCF, osteoporotic vertebral compression fracture; HWE, Hardy-Weinberg; FDR, false discovery rate. Adjusted for age, hypertension, diabetes mellitus. OR, odds ratio; OVCF, osteoporotic vertebral compression fracture; FDR, false discovery rate; MDR, multifactor-dimensionality reduction.
p Value determined by Fisher's exact test.
MICRORNA POLYMORPHISMS IN OVCF quencies were calculated to identify deviations from HardyWeinberg equilibrium (HWE) using p ¼ 0.05 as a threshold.
To estimate the relative risk of the various genotypes for patients with osteoporosis in the non-OVCF and OVCF groups, the odds ratio (OR) and 95% confidence interval (CI) were calculated. ANOVA (analysis of variance) was used for analysis of the association of the various genotypes with BMD, body mass index (BMI), DBP, SBP, and levels of folate, glucose, homocysteine, HDL, LDL, TG, and vitamin B12. A probability (p) value of 0.05 was considered to indicate statistical significance. ORs were adjusted by possible confounders such as age, sex, DM, hypertension, serum folate, and serum vitamin B12. We performed hypothesis testing by the Benjamini-Hochberg method to confirm the false discovery rate (FDR) in the unconditional logistic regression analysis. The FDR addresses the multiple comparison problems and provides a measure of the expected proportion of false positive findings among total number of positive findings. Statistical analyses were performed using GraphPad Prism 4.0 software (GraphPad Software, Inc., San Diego, CA) and StatsDirect version 2.4.4 software (StatsDirect Ltd., Altrincham, UK), or HAPSTAT 3.0 (University of North Carolina, Chapel Hill, NC).
RESULTS
Study Population
The characteristics of the study subjects are shown in Table 1 . The mean age in the control group and osteoporosis group was 66.6 AE 6.5 years and 67.9 AE 6.1 years, respectively. Of the 112 subjects with osteoporosis, 57 exhibited vertebral compression fractures. Women without OVCF were significantly older (66.6 AE 6.5 years vs. 68.4 AE 5.4 years) than those in the control group. Women with osteoporosis had a higher prevalence of hypertension, higher glucose level, lower LDL cholesterol, and lower vitamin B12 level compared with the control group. Women with OVCF had a lower folate level and higher LDL level than those in the control group (Table 1 ). An examination of the independent effect of each variable on OVCF status by multiple logistic regression analysis revealed no significant association with increased risk of OVCF (Tables S1 and S2 ).
Genotype Frequencies of the miRNA Polymorphisms
We evaluated the genotype frequencies of the miR146aC>G, miR-149T>C, miR-196a2, and miR-499A>G polymorphisms among the three groups (control, non-OVCF, OVCF groups). The genotype distributions of these four SNPs were in agreement with the HardyWeinberg equilibrium. We estimated the adjusted OR (AOR) from logistic regression analyses with respect to age, sex, DM, hypertension, and serum level of cholesterol, folate, homocysteine, and vitamin B12.
Among these four miRNA polymorphisms, the frequency of the TC genotype of the miR-149T>C polymorphism was less frequent in osteoporosis group, suggesting a protective effect against osteoporosis risk (TT versus TC: AOR, 0.555; 95%CI, 0.324-0.949, p ¼ 0.031). In addition, the TC genotype and CT þ CC genotype of the miR-149T>C polymorphism were less frequent in OVCF group, suggesting a protective effect against OVCF risk (TT versus TC Tables 2 and S3) .
We analyzed the combined genotype frequencies of miR-146aC>G, miR-149T>C, miR-196a2, and miR-499A>G. There were no significant differences when the control group was compared with osteoporosis patients and the non-OVCF group. However, when the Table 3 ). In addition, we conducted an allele-based multifactor dimensionality reduction analysis (Table 4) . When osteoporosis patients were compared with controls, the G-T (miR-146a/-196a2) , G-T-T (miR-146a/-149/-196a2), G-T-G (miR-146a/-149/-499), and G-T-C-G (miR-146a/-149/-196a2/-449) genotypes were significantly associated with an increased risk of osteoporosis (p < 0.05). Conversely, the G-C-G (miR-146a/-149/-499) and C-C-G (miR-149/-196a2/-499) genotypes were significantly less frequent in patients with osteoporosis. When the OVCF group was compared with controls, six allele combinations (miR-146aG/-149T, miR-146aG/-196a2T, miR-149T/-499A, miR-146aG/-149T/-196a2T, miR-146aG/-149T/-196a2T/-449A, and miR-146aG/-149T/-196a2C/-449G, p < 0.05) were significantly associated with an increased risk of OVCF, whereas seven allele combinations (miR146aC/-196a2T, miR-146aC/-499G, miR-146aG/-149C/-196a2C, miR-146aC/-149T/-499G, miR-149T/-196a2T/-499G, miR-146aC/-149T/-196a2T/-449G, and miR-146aG/-149C/-196a2C/-449A, p < 0.05) were significantly associated with a decreased risk of OVCF. Among those combinations, the combination of miR-146aG/-149T/-196a2C/-449G increased the risk of OVCF with the highest odds ratios of 24.03 and 35.01, respectively ( Table 4) .
The association of the four miRNA polymorphisms with BMI and serum level of folate, homocysteine, vitamin B12, and BMD was analyzed using ANOVA. There were significant associations of polymorphisms of miR-146 and miR-196a2 with BMD (Table 5) .
DISCUSSION
OVCFs are common in the elderly population and are associated with high rates of morbidity and mortality; thus, the prevention of major osteoporotic fractures is important. 3, 32 Although novel clinical, biochemical, and imaging tools have been developed to improve the assessment of fracture risk, predicting OVCFs is a major challenge. Currently, DXA and clinical fracture risk prediction tools such as FRAX (Fracture Risk Assessment Tool) are used to estimate an individual's risk of osteoporotic fracture. 33 Although osteoporotic facture risk increases with decreases in BMD, the vast majority of osteoporotic fractures occur in osteopenic patients (BMD T-score of the spine or hip lies between À1 and À2.5).
34 Therefore, OVCF risk is affected by both genetic and environmental factors. Many new genetic regions have been identified to associated with osteoporosis or OVCF, and the candidate gene variants for osteoporotic fracture are not always the same as those for low BMD. 35 In this study, we investigated polymorphisms of miR-146a (rs2910164), miR-149 (rs2292832), miR-196a2 (rs11614913), and miR-499 (rs3746444) in Korean postmenopausal women to determine whether they are independent factors for OVCF.
miR-146a plays an important role in regulating bone remodeling and functions as a positive regulator in osteoblasts by driving commitment of MSCs to an osteogenic fate. 27 ,36 miR-146a has been shown to suppress osteoclastogenesis. 27, 37 miR-196a2 plays a crucial role in development of the axial skeleton and enhances commitment of MSCs towards the osteoblast lineage. 27, 36 Because miR-149 and miR-449 target inflammatory cytokines, an association between these SNPs and osteoporosis and/or OVCF might exist. 27 The results of our study suggest that the miR146aCG/miR-196a2TC combined genotype was significantly associated with OVCF in Korean postmenopausal women, as the frequency of miR-146aCG miR196a2TC was significantly increased in OVCF patients compared the control group. In addition, allele-allelic combination analysis revealed that the various combinations were significantly associated with OVCF risk, suggesting putative gene-gene interactions. Among them, the combination of miR-146aG/-149T/-196a2C/-449G showed the strongest relationship with OVCF risk. In contrast, the TC þ CC genotype of miR-149T>C was significantly associated with a reduced risk of OVCF because the genotype was significantly less frequent in OVCF patients than in the control group. Our analyses therefore suggest that miR146a/-149/-196a2/-499 could play a role in the pathogenesis of osteoporosis and OVCF. These findings collectively suggest that miR-149-rs2292832-C may have a protective function against OVCF and that the miR-146aCG/miR-196a2TC combined genotype and miR-146aG/-149T/-196a2C/-449G allele combination may be independent factors for OVCF in Korean postmenopausal women.
Understanding the potential roles of these four miRNAs as novel predictors of OVCF independent of BMD is important for elucidating the susceptibility to OVCF. However, our results should be interpreted with caution as we did not demonstrate in vitro functional effects of genetic variations in miR-146a, -149, -196a2, and -499, and we did not analyze miRNA-target interactions.
There are several limitations associated with this study. First, this study included only Korean postmenopausal women, and our results cannot be generalized to other racial/ethnic groups because SNPs and alleleallelic combination types vary among ethnic groups. Thus, the present results should be replicated and validated in other ethnic groups and in men. Second, this was a hospital-based case-control study, and the sample size was relatively small. Third, we could not conclusively exclude other potential confounding variables such as exposure to different environmental factors (e.g., smoking, nutrition, and the amount of calcium and vitamin intake) and additional genetic risk factors. Fourth, we did not identify targets of miR-146a/-149/-196a2/-499 involved in the development of osteoporosis and OVCF. In the future, in vitro studies validating miRNA-target interactions should resolve these limitations and confirm the findings.
In conclusion, we demonstrated that the miR-149T>C genotype was significantly associated with decreased OVCF risk, and the combined genotype of miR-146aCG/-196a2TC was significantly associated with increased OVCF risk. Our results suggest that various putative gene-gene interactions among miR146a, miR-149, miR-196a2, and miR-499 could be used to predict OVCF risk in Korean postmenopausal women. In particular, the combination of miR146aG/-149T/-196a2C/-449G was associated with a high risk of osteoporosis and OVCF. Based on our findings, analysis of miR-146aC>G, miR-149T>C, miR-196a2T>C, and miR-499A>G in osteoporosis patients could help to improve the accuracy of OVCF risk assessment, and the data may contribute to the pool of SNP variants needed for individual OVCF risk assessment. However, the impact of a single variant on OVCF is small, and a cumulative effect of multiple variants and a complex network may underlie the pathogenesis of osteoporosis and OVCF. Therefore, identification of a larger number of gene variants that affect the pathogenesis of OVCF is necessary before substantial clinical gains in predicting fracture risk can be realized.
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